# LYRICA CR
> **NDA209501** · New Drug Application · Sponsor: UPJOHN · Approved 2017-10-11
## Drug
- **FDA Application Number:** NDA209501
- **Application type:** New Drug Application
- **Brand name:** LYRICA CR
- **Generic name:** PREGABALIN
- **Active ingredients:** PREGABALIN
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** UPJOHN
- **Manufacturer:** Viatris Specialty LLC
- **First approval:** 2017-10-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209501)
---
*MORVS · CC0 1.0*